What we found on the web about Cangene
Apotex - Wikipedia, the free encyclopedia
Apotex owns 61% of Cangene Corp., a Winnipeg-based biopharmaceutical company, according to Cangene's 2007 annual report. Cangene's business focuses are hyperimmunes, contract ...
Rh disease - Wikipedia, the free encyclopedia
Cangene was purchased by the Winnipeg Rh Institute, a facility founded by Chown and Bowman and dedicated to conducting research into blood related diseases.
Cangene Corporation - Company Details - Contract Services Directory ...
Contact: David Young Sales Manager, Contract Manufacturing Email: contractmanufacturing@cangene.com Website: www.cangene.com: Address: 155 Innovation Drive
CNJ.TO: Summary for CANGENE CORP COM NPV - Yahoo! Finance
Get detailed information on CANGENE CORP COM NPV (CNJ.TO) including quote performance, Real-Time ECN, technical chart analysis, key stats, insider transactions, and the latest ...
Cangene Signs VIG Supply Pact with DoD - Contract Pharma
The Chemical Biological Medical Systems Project Management Office of the U.S. Department of Defense (DoD) has signed a four-year agreement with Cangene Corp. to purchase its ...
CANGENE CORPORATION | Cangene's VIG (Vaccinia Immune Globulin ...
Listed TSX, Symbol: CNJ TORONTO and WINNIPEG, Aug. 16 /CNW/ - Cangene Corporation today reports that its contract with the U.S. Centers for Disease Control and Prevention for ...
CANGENE CORPORATION | Cangene to host third quarter fiscal 2009 ...
Listed TSX, Symbol: CNJ TORONTO and WINNIPEG, June 10 /CNW/ - Cangene Corporation today announces that it intends to host a conference call on Friday, June 12, 2009 at 11:00 a ...
Cangene to acquire U.S. commercialization rights for HepaGam B
Cangene Corporation today announces that it has signed an agreement with its majority shareholder, the Apotex Group, under which Cangene acquires all U.S. commercialization rights ...
Christwater-Americas: Tenergy Christ Water LLC is Selected by Cangene
Tenergy Christ Water LLC of New Britain, Connecticut announced that they have been selected by Cangene Corporation to provide a Duplex 33 gpm USP water system for a new ...
Cangene Corporation (CNJ) Company Profile - CorporateInformation.com
Cangene Corporation. The Group's principal activities are to develop and distribute hyperimmune products and recombinant biopharmaceuticals. Hyperimmune products are specialty ...
Entry added by Creative Administrator
Creative Administrator also edited:
Here is what users have to say about Cangene

Welcome to CWAnswers

CWAnswers is your guide to the sprawling world wide web. The directory aims to provide a useful guide made by users. You can share your knowledge as well - simply register and edit your first entry. For questions just contact the team at support - at - cwanswers.com.

Weblinks

Top 10

Things you find nowhere else.

Comments

You must be logged in to post a comment.

No comments yet on this topic. Be the first one!
These recent articles mention Cangene
Markets close higher led by consumer stocks and financials
Toronto Star
Cangene Corp.'s (TSX: CNJ) shares jumped $1.84 or 40.44 per cent to $6.39 after it reported profit rose year over year to $59.9 million – its highest ever annual net income. The showing represented a gain of 102 per cent from a year earlier...
Cangene books best-ever annual profit, gets a boost from U.S ...
News1130.com
WINNIPEG - Cangene Corp. (TSX:CNJ) has booked its highest ever annual net income, helped by a dramatic increase in deliveries on U.S. government contracts, the biopharmaceutical company said Thursday. For the fiscal year ended July 31, its ...
SADIF Analytics releases new summary due diligence report for Cangene ...
PR Inside
2009-10-09 13:50:28 - SADIF-Investment Analytics has applied its StockMarks™ stock-rating system to Cangene Corporation and produced a report, rating the company's attractiveness to long-term investors. Ilhavo, Portugal – 09/10/2009 – SADIF...
Cangene makes sale to new, international customer
Phramalive.com
TORONTO and WINNIPEG, Sept. 22 /CNW/ - Cangene Corporation today announces that it has finalized two contracts with a non-North American government for a supply of Cangene's vaccinia immune globulin ("VIG") and botulism antitoxin ("BAT"). T...
Maxygen, Astellas complete joint venture
San Francisco Business Journal
Maxygen will continue to hold $185 million cash and its MAXY-G34 neutropenia program for cancer patients, including a licensing arrangement with Cangene Corp. for acute radiation syndrome. It also maintains a 22 percent ownership interest i...
Biosimilar Market Fails to Meet Projections
Genetic Engineering News
Some of the leaders emerging in the market are Cangene, Biocon, Sandoz, TEVA, and Dr. Reddy’s. Having successfully marketed biogeneric products in Europe and Asia, these companies will come prepared to the new market. Among biological produ...
Canadian News
RTT News
Cangene Corp. (CNJ.TO) soared more than 40% after the company reported full-year net income of C$59.9 million or C$0.86 per share, compared with C$29.6 million or C$0.42 per share a year earlier. On the economic front, Stats Canada reported...
Smallpox Vaccine
Center for Food Safety and Applied Nutrition
ACAM2000 was approved on August 31, 2007, and is intended for inoculation of people at high risk of exposure to smallpox. In addition, on May 2, 2005, CBER licensed Vaccinia Immune Globulin, Intravenous (VIGIV) manufactured by Cangene Corpo...
Canadian Stocks Rise as Harvest Offer Spurs Merger Speculation
Bloomberg
Winnipeg-based pharmaceutical maker Cangene Corp. rallied 40 percent, the most in 14 years, to C$6.39 after the company reported net income of C$21.9 million, or 32 cents a share in the fourth quarter, up from C$18.7 million, or 27 cents a ...